LOCOREGIONAL RECURRENCE
Clinical trials for LOCOREGIONAL RECURRENCE explained in plain language.
Never miss a new study
Get alerted when new LOCOREGIONAL RECURRENCE trials appear
Sign up with your email to follow new studies for LOCOREGIONAL RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a targeted pill stop breast Cancer's return? new trial hopes to find out
Disease control Recruiting nowThis phase 3 trial tests whether adding the targeted drug abemaciclib to standard hormone therapy can prevent breast cancer from coming back in people with HR-positive, HER2-negative breast cancer who have already had a local recurrence. About 290 participants will receive either…
Matched conditions: LOCOREGIONAL RECURRENCE
Phase: PHASE3 • Sponsor: Japanese Foundation for Cancer Research • Aim: Disease control
Last updated Jun 02, 2026 11:59 UTC
-
Promising drug cocktail aims to stop breast cancer recurrence
Disease control Recruiting nowThis study is for people with a type of breast cancer (hormone receptor-positive, HER2-negative) that has come back in the same area after initial treatment. The goal is to see if adding the drug ribociclib to standard hormone therapy can help prevent the cancer from returning ag…
Matched conditions: LOCOREGIONAL RECURRENCE
Phase: PHASE2 • Sponsor: Oana Danciu • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
New study aims to improve treatment for recurrent breast cancer
Knowledge-focused Recruiting nowThis study follows 500 breast cancer patients whose cancer has returned in the same area. They receive radiation again, with or without heat therapy (hyperthermia). The goal is to track side effects, quality of life, and survival to help doctors and patients make better treatment…
Matched conditions: LOCOREGIONAL RECURRENCE
Sponsor: Amsterdam UMC, location VUmc • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC